A critical breakthrough in cancer investigation is occurring with the use of mini-antibodies to re-engage mutated p53. This crucial cancer suppressor protein is frequently disabled in various forms of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research